These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 19391263)

  • 1. Side effects and complications. HAART and the safety of the fetus.
    TreatmentUpdate; 2009 Feb; 21(2):6-7. PubMed ID: 19391263
    [No Abstract]   [Full Text] [Related]  

  • 2. Side effects and complications. Risk of deformities very low in infants exposed to HAART.
    TreatmentUpdate; 2009 Feb; 21(2):8-9. PubMed ID: 19391265
    [No Abstract]   [Full Text] [Related]  

  • 3. Side effects and complications. French study clears HAART of cancer link in kids.
    TreatmentUpdate; 2009 Feb; 21(2):7-8. PubMed ID: 19391264
    [No Abstract]   [Full Text] [Related]  

  • 4. Twins with cardiomyopathy and complete heart block born to an HIV-infected mother treated with HAART.
    Lopriore E; Rozendaal L; Gelinck LB; Bökenkamp R; Boelen CC; Walther FJ
    AIDS; 2007 Nov; 21(18):2564-5. PubMed ID: 18025905
    [No Abstract]   [Full Text] [Related]  

  • 5. Antiretroviral therapy during pregnancy and the risk of an adverse outcome.
    Thorne C; Fiore S; Rudin C
    N Engl J Med; 2003 Jan; 348(5):471-2; author reply 471-2. PubMed ID: 12556551
    [No Abstract]   [Full Text] [Related]  

  • 6. [Treatment of HIV-infected pregnant women: prevention of virus transmission and adverse effects in mother and child].
    Boer K; Nellen JF; Kreyenbroek ME; Godfried MH
    Ned Tijdschr Geneeskd; 2009; 153():B410. PubMed ID: 19785876
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antiretroviral drug use during pregnancy and risk of premature delivery: is there a connection?
    Kourtis AP
    J Infect Dis; 2010 Apr; 201(7):978-80. PubMed ID: 20196653
    [No Abstract]   [Full Text] [Related]  

  • 8. Response to Kourtis et al. 'Use of antiretroviral therapy in pregnant HIV-infected women and the risk of premature delivery: a meta-analysis'.
    Townsend CL; Cortina-Borja M; Peckham CS; Tookey PA
    AIDS; 2007 Aug; 21(13):1831-2. PubMed ID: 17690590
    [No Abstract]   [Full Text] [Related]  

  • 9. Methylmalonic acidaemia in a 7-month-old following maternal highly active antiretroviral therapy during pregnancy.
    Silf K; McMaster P; Hendriksz C
    AIDS; 2007 Aug; 21(13):1835-6. PubMed ID: 17690593
    [No Abstract]   [Full Text] [Related]  

  • 10. Pregnancy and HIV.
    Kaplan S; Cohen H
    N Engl J Med; 1992 Aug; 327(9):646-7. PubMed ID: 1640966
    [No Abstract]   [Full Text] [Related]  

  • 11. Effects of antiretroviral therapy on occurrence of pre-eclampsia.
    Mawson AR
    Lancet; 2003 Jan; 361(9354):347-8. PubMed ID: 12559889
    [No Abstract]   [Full Text] [Related]  

  • 12. Successful use of darunavir, etravirine, enfuvirtide and tenofovir/emtricitabine in pregnant woman with multiclass HIV resistance.
    Furco A; Gosrani B; Nicholas S; Williams A; Braithwaite W; Pozniak A; Taylor G; Asboe D; Lyall H; Shaw A; Kapembwa M
    AIDS; 2009 Jan; 23(3):434-5. PubMed ID: 19188762
    [No Abstract]   [Full Text] [Related]  

  • 13. [HAART and pregnancy. Nelfinavir superiority in hepatotoxicity].
    MMW Fortschr Med; 2004 Apr; 146 Spec No 1():45. PubMed ID: 15373048
    [No Abstract]   [Full Text] [Related]  

  • 14. Management and outcome of HIV in pregnancy.
    Unsworth J; Farazmand P; Chan K; Kingston M; McQuillan O; Wilson S; Tower C
    Eur J Obstet Gynecol Reprod Biol; 2011 Sep; 158(1):110-1. PubMed ID: 21501920
    [No Abstract]   [Full Text] [Related]  

  • 15. Women and HIV.
    Laurence J
    AIDS Read; 2007 Dec; 17(12):574, 580. PubMed ID: 18178972
    [No Abstract]   [Full Text] [Related]  

  • 16. HAART patients at greater risk of severe side effects than AIDS.
    Carter M
    IAPAC Mon; 2003 Dec; 9(12):314. PubMed ID: 15055163
    [No Abstract]   [Full Text] [Related]  

  • 17. Obstetric and newborn infant outcomes in human immunodeficiency virus-infected women who receive highly active antiretroviral therapy.
    Haeri S; Shauer M; Dale M; Leslie J; Baker AM; Saddlemire S; Boggess K
    Am J Obstet Gynecol; 2009 Sep; 201(3):315.e1-5. PubMed ID: 19733286
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effect of pregnancy on HIV disease progression during the era of highly active antiretroviral therapy.
    Chen PL; Weaver M; Kwok C; Morrison CS
    J Infect Dis; 2008 Apr; 197(7):1075-6; author reply 1076-7. PubMed ID: 18419544
    [No Abstract]   [Full Text] [Related]  

  • 19. Anti-HIV agents. A few reasons for starting therapy at CD4+ counts above 350 cells.
    TreatmentUpdate; 2009 Jan; 21(1):4-5. PubMed ID: 19248283
    [No Abstract]   [Full Text] [Related]  

  • 20. Influence of highly active antiretroviral treatment (HAART) on risk factors for vertical HIV transmission.
    Garcia-Tejedor A; Maiques V; Perales A; Lopez-Aldeguer J
    Acta Obstet Gynecol Scand; 2009; 88(8):882-7. PubMed ID: 19557554
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.